<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="and its use in COVIDâ€�19. CP may be an adjunctive" exact="treatment" post="option to the antiâ€�viral therapy. The protective effect of"/>
 <result pre="therapeutics, CP seems to be a safe and probably effective" exact="treatment" post="for critically ill patients with COVIDâ€�19. It could also"/>
 <result pre="number of infected cases, it is important to find a" exact="treatment" post="in a short time. Passive antibody therapy involves administering"/>
 <result pre="Cheng et al evaluated the efficacy of CP in the" exact="treatment" post="of patients with SARS in 2003 and found a"/>
 <result pre="has been used in the recent global outbreak for the" exact="treatment" post="of patients with COVIDâ€�19 in China. In the study"/>
 <result pre="when vaccines and antiâ€�viral drugs are not available in the" exact="treatment" post="of critically ill patients with COVIDâ€�19.16 Turkish Ministry of"/>
 <result pre="experience sharing among themselves by following donor selection, product standard," exact="treatment" post="management, patientâ€�donor followâ€�up, and scientific developments in the world."/>
 <result pre="serological test for SARSâ€�CoVâ€�2 antibodies after recovery, if prior diagnostic" exact="testing" post="was not performed at the time COVIDâ€�19 was suspected."/>
 <result pre="reverse transcriptaseâ€�PCR (RTâ€�PCR) is currently a favored assay for the" exact="detection" post="of coronavirus. However, RNA detectability was low in samples"/>
 <result pre="dayâ€�7 and during days 15â€�39. For this reason, coronavirus preâ€�donation" exact="screening" post="tests should be supported by antibody detecting tests.20 Each"/>
 <result pre="In addition, a blood sample should be obtained for antibody" exact="testing" post="before referring the donor to an apheresis procedure. Unfortunately,"/>
 <result pre="previous study, the efficacy of the antibody test for the" exact="detection" post="of IgM and IgG, has shown a sensitivity and"/>
 <result pre="combining RNA and antibody detections significantly improved the sensitivity of" exact="diagnosis" post="for COVIDâ€�19 in the first 1â€�week since onset.26 Currently,"/>
 <result pre="titers of antibodies.22, 23, 24, 25 According to FDA if" exact="testing" post="can be conducted, neutralizing antibody titers should be at"/>
 <result pre="of 1:160 was used.10 A quarter or half of the" exact="treatment" post="dose was used for prophylactic purposes in earlier studies."/>
 <result pre="hepatitis B and hepatitis C viruses, the risk of transfusionâ€�transmissible" exact="infection" post="is less than one infection per two million donations.34"/>
 <result pre="viruses, the risk of transfusionâ€�transmissible infection is less than one" exact="infection" post="per two million donations.34 The risk of TRALI is"/>
 <result pre="by a different viral serotype may exacerbate clinical severity.39 Previous" exact="infection" post="with other types of coronavirus may arise the concern"/>
 <result pre="a natural immune response, especially when administered for prophylaxis. CP" exact="treatment" post="is recommended only in academic or comprehensive centers that"/>
 <result pre="TRALI. In conclusion, SARSâ€�CoVâ€�2 continues to spread worldwide. The exact" exact="treatment" post="of COVIDâ€�19 disease is currently unknown. Even though limited"/>
 <result pre="therapeutics, CP seems to be a safe and probably effective" exact="treatment" post="for critically ill patients with COVIDâ€�19. At least preliminary"/>
 <result pre="2020;55:200054710.1183/13993003.00547-2020.32217650 6GrahamBS, AmbrosinoDM. History of passive antibody administration forprevention and" exact="treatment" post="of infectious diseases. Curr Opin HIV AIDS. 2015;10:129â€�134.25760933 7BlochEM,"/>
 <result pre="CasadevallA, et al. Deployment ofconvalescent plasma for the prevention and" exact="treatment" post="of COVIDâ€�19. J Clin Invest. 2020;130:2757â€�2765. 10.1172/JCI138745.32254064 8SooYO, ChengY,"/>
 <result pre="et al. Retrospective comparison of convalescent plasma with continuinghighâ€�dose methylprednisolone" exact="treatment" post="in SARS patients. Clin Microbiol Infect. 2004;10:676â€�678.15214887 9YehKM, ChiuehTS,"/>
 <result pre="van KasterenPB. Fcâ€�mediated antibody effector functions during respiratory syncytial virus" exact="infection" post="and disease. Front Immunol. 2019;10:548.30967872 19GunnBM, YuWH, KarimMM, et"/>
 <result pre="application of a rapid IgMâ€�IgG combined antibody test for SARSâ€�CoVâ€�2" exact="infection" post="diagnosis. J Med Virol. 202010.1002/jmv.25727. 24GuoL, RenL, YangS, et"/>
 <result pre="Immunol. 2003;24:474â€�478.12967670 31CasadevallA, ScharffMD. Serum therapy revisited: animal models of" exact="infection" post="and development of passive antibody therapy. Antimicrob Agents Chemother."/>
</results>
